| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-05 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-05 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-05 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-05 |
| mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.23 |
3e-05 |
| mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
-0.19 |
4e-05 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-05 |
| mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
6e-05 |
| mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
6e-05 |